Cargando…

Novel Type 2 Diabetes Medication Access and Effect of Patient Cost Sharing

BACKGROUND: Although drug formulary restrictions may reduce use of prescription medication and pharmacy costs, the effect of patient cost sharing on medication adherence and health care utilization and cost is unclear. OBJECTIVE: To evaluate the relationship between patient cost sharing for novel ty...

Descripción completa

Detalles Bibliográficos
Autores principales:	Henk, Henry J., Lopez, Janice M. S., Bookhart, Brahim K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academy of Managed Care Pharmacy 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10397984/ https://www.ncbi.nlm.nih.gov/pubmed/30156451 http://dx.doi.org/10.18553/jmcp.2018.24.9.847

Ejemplares similares

Healthcare Resource Utilization and Costs of Rivaroxaban Versus Warfarin Among Nonvalvular Atrial Fibrillation Patients with Obesity and Diabetes
por: Weir, Matthew R., et al.
Publicado: (2021)

Direct All-Cause Health Care Costs Associated With Chronic Kidney Disease in Patients With Diabetes and Hypertension: A Managed Care Perspective
por: Laliberte, Francois, et al.
Publicado: (2009)

Healthcare Resource Utilization and Costs of Rivaroxaban Versus Warfarin Among Non-valvular Atrial Fibrillation (NVAF) Patients with Diabetes in a US Population
por: Berger, Jeffrey S., et al.
Publicado: (2023)

Physicians’ perspectives regarding non-medical switching of prescription medications: Results of an internet e-survey
por: Salam, Tabassum, et al.
Publicado: (2020)

Impact of non-medical switching of prescription medications on health outcomes: an e-survey of high-volume medicare and medicaid physician providers
por: Coleman, Craig, et al.
Publicado: (2020)

Specialist physician perspectives on non-medical switching of prescription medications
por: Costa, Olivia S., et al.
Publicado: (2020)

Shorter Hospital Stays and Lower Costs for Rivaroxaban Compared With Warfarin for Venous Thrombosis Admissions
por: Margolis, Jay M., et al.
Publicado: (2016)

Type 2 diabetes: cost-effectiveness of medication adherence and lifestyle interventions
por: Nerat, Tomaž, et al.
Publicado: (2016)

Direct Medical Cost of Type 2 Diabetes in Singapore
por: Shuyu Ng, Charmaine, et al.
Publicado: (2015)

Improving access to shared decision-making for Hispanics/Latinos with inadequately controlled type 2 diabetes mellitus
por: Davidson, Jaime A, et al.
Publicado: (2015)

A Shared Drive: Securing Patient Access to High-Cost Medicines
por: van der Ent, Leendert
Publicado: (2017)

Unintended Consequences of Increased Out-of-Pocket Costs During Medicare Coverage Gap on Anticoagulant Discontinuation and Stroke
por: Salam, Tabassum, et al.
Publicado: (2023)

Prevalence of Sharing Access Credentials in Electronic Medical Records
por: Hassidim, Ayal, et al.
Publicado: (2017)

The impact of non-medical switching among ambulatory patients: an updated systematic literature review
por: Weeda, Erin R., et al.
Publicado: (2019)

Effect of cost sharing on adherence to evidence-based medications in patients with acute coronary syndrome
por: González López-Valcárcel, Beatriz, et al.
Publicado: (2017)

Effectiveness and Safety of Rivaroxaban Versus Warfarin among Nonvalvular Atrial Fibrillation Patients with Concomitant Obstructive Sleep Apnea
por: Sood, Nitesh, et al.
Publicado: (2023)

Development of predictive risk models for major adverse cardiovascular events among patients with type 2 diabetes mellitus using health insurance claims data
por: Young, James B., et al.
Publicado: (2018)

Commentary: Patient Cost Sharing and Medical Expenditures for the Elderly
por: Jakovljevic, Mihajlo
Publicado: (2016)

Barriers Associated with Access to Prescription Medications in Patients Diagnosed with Type 2 Diabetes Mellitus Treated at Federally Qualified Health Centers
por: Ali, Asma M., et al.
Publicado: (2022)

Impact of Once-Daily Versus Twice-Daily Dosing Frequency on Adherence to Chronic Medications among Patients with Venous Thromboembolism
por: Laliberté, François, et al.
Publicado: (2013)

Shared decision-making: the perspectives of young adults with type 1 diabetes mellitus
por: Wiley, Janice, et al.
Publicado: (2014)

Association of Prescription Abandonment with Cost Share for High-Cost Specialty Pharmacy Medications
por: Gleason, Patrick, et al.
Publicado: (2009)

Shared Medical Appointments and Mindfulness for Type 2 Diabetes—A Mixed-Methods Feasibility Study
por: Ee, Carolyn, et al.
Publicado: (2020)

All-Cause and Potentially Disease-Related Health Care Costs Associated with Venous Thromboembolism in Commercial, Medicare, and Medicaid Beneficiaries
por: Lefebvre, Patrick, et al.
Publicado: (2012)

Direct medical cost associated with diabetic retinopathy severity in type 2 diabetes in Singapore
por: Zhang, Xiao, et al.
Publicado: (2017)

Effectiveness of shared goal setting and decision making to achieve treatment targets in type 2 diabetes patients: A cluster‐randomized trial (OPTIMAL)
por: Den Ouden, Henk, et al.
Publicado: (2017)

Shared Medical Appointments May Be Effective for Improving Clinical and Behavioral Outcomes in Type 2 Diabetes: A Narrative Review
por: Menon, Kirthi, et al.
Publicado: (2017)

The effects of patient cost sharing on inpatient utilization, cost, and outcome
por: Xu, Yuan, et al.
Publicado: (2017)

The direct medical cost of type 2 diabetes mellitus in South Africa: a cost of illness study
por: Erzse, Agnes, et al.
Publicado: (2019)

Knowledge sharing in global health research – the impact, uptake and cost of open access to scholarly literature
por: Smith, Elise, et al.
Publicado: (2017)

The Cost-Effectiveness of Supplemental Carnosine in Type 2 Diabetes
por: Menon, Kirthi, et al.
Publicado: (2022)

Costs and Consequences Associated With Newer Medications for Glycemic Control in Type 2 Diabetes
por: Sinha, Anushua, et al.
Publicado: (2010)

Distinct and shared genetic architectures of Gestational diabetes mellitus and Type 2 Diabetes Mellitus
por: Elliott, A., et al.
Publicado: (2023)

Correction: The effects of patient cost sharing on inpatient utilization, cost, and outcome
por: Xu, Yuan, et al.
Publicado: (2018)

Shared resources, shared costs—leveraging biocuration resources
por: Orchard, Sandra, et al.
Publicado: (2015)

Global Implications for COVID-19 Vaccine Series Completion: Insights from Real-World Data from the United States
por: DeMartino, Jessica K., et al.
Publicado: (2022)

Cost-effectiveness and cost-utility analysis of type-2 diabetes screening in pharmacies in Iran
por: Amirsadri, Mohammadreza, et al.
Publicado: (2023)

Estimated Cost-effectiveness of Medical Therapy, Sleeve Gastrectomy, and Gastric Bypass in Patients With Severe Obesity and Type 2 Diabetes
por: Lauren, Brianna N., et al.
Publicado: (2022)

Direct Medical Costs of Type 2 Diabetes in France: An Insurance Claims Database Analysis
por: Charbonnel, Bernard, et al.
Publicado: (2017)

Cost of medication adherence and persistence in type 2 diabetes mellitus: a literature review
por: Kennedy-Martin, Tessa, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_0vdocojh1mmc3cmhfkttu9evb2